Evidence map›Paper›PMID 37124629›Full record

ArticleBiomicrofluidics2023

Ultraviolet control of bacterial biofilms in microfluidic chips.

Gabriel Ramos, Clara Toulouze, Maya Rima, Olivier Liot, Paul Duru, Yohan Davit

Open access · greenAbstract read
In one paragraph

Article in Biomicrofluidics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 9 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Gabriel RamosInstitut de Mécanique des Fluides (IMFT), CNRS and Université de Toulouse, 31400 Toulouse, France.ORCID 0000-0002-5978-3519
Clara ToulouzeInstitut de Mécanique des Fluides (IMFT), CNRS and Université de Toulouse, 31400 Toulouse, France.ORCID 0009-0007-5950-7112
Maya RimaLaboratoire de Génie Chimique (LGC), Université de Toulouse, CNRS, INPT, UPS, 31062 Toulouse, France.ORCID 0000-0002-4211-2583
Olivier LiotInstitut de Mécanique des Fluides (IMFT), CNRS and Université de Toulouse, 31400 Toulouse, France.ORCID 0000-0001-5192-0120
Paul DuruInstitut de Mécanique des Fluides (IMFT), CNRS and Université de Toulouse, 31400 Toulouse, France.ORCID 0000-0002-9171-8266
Yohan DavitInstitut de Mécanique des Fluides (IMFT), CNRS and Université de Toulouse, 31400 Toulouse, France.ORCID 0000-0002-2234-9567
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polydimethylsiloxane (PDMS) microfluidic systems have been instrumental in better understanding couplings between physical mechanisms and bacterial biofilm processes, such as hydrodynamic effects. However, precise control of the growth conditions, for example, the initial distribution of cells on the substrate or the boundary conditions in a flow system, has remained challenging. Furthermore, undesired bacterial colonization in crucial parts of the systems, in particular, in mixing zones or tubing, is an important factor that strongly limits the duration of the experiments and, therefore, impedes our ability to study the biophysics of biofilm evolving over long periods of time, as found in the environment, in engineering, or in medicine. Here, we develop a new approach that uses ultraviolet-C (UV-C) light-emitting diodes (LEDs) to confine bacterial development to specific zones of interest in the flow channels. The LEDs are integrated into a 3D printed light guide that is positioned upon the chip and used to irradiate germicidal UV-C directly through the PDMS. We first demonstrate that this system is successful in controlling undesired growth of

Identifiers

PMID37124629
PMCPMC10132849
OpenAlexW4367280983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.